Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) Sees Large Increase in Short Interest

Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) was the target of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 23,657 shares, a growth of 1,351.3% from the July 30th total of 1,630 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Towa Pharmaceutical Stock Performance

Shares of TWAPF stock opened at $25.98 on Wednesday. Towa Pharmaceutical has a fifty-two week low of $25.71 and a fifty-two week high of $26.00. The stock has a 50 day simple moving average of $25.81 and a two-hundred day simple moving average of $25.50.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley raised shares of Towa Pharmaceutical to an “overweight” rating in a research report on Friday, June 12th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, Towa Pharmaceutical presently has an average rating of “Buy”.

Institutional Trading of Towa Pharmaceutical

An institutional investor recently bought a new position in Towa Pharmaceutical stock. Public Employees Retirement System of Ohio bought a new stake in shares of Towa Pharmaceutical Co., Ltd. (OTCMKTS:TWAPF) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 96,968 shares of the company’s stock, valued at approximately $3,285,000.

About Towa Pharmaceutical

Towa Pharmaceutical Co, Ltd. (OTCMKTS:TWAPF) is a Japan-based healthcare company primarily engaged in the research, development, manufacturing and sale of pharmaceutical products. The company’s product portfolio spans active pharmaceutical ingredients (APIs), finished dosage forms such as tablets and capsules, and over-the-counter (OTC) preparations. Towa Pharmaceutical serves both prescription and consumer healthcare markets, offering formulations that address chronic conditions, lifestyle-related illnesses and general wellness.

In addition to its in-house product lines, Towa Pharmaceutical provides contract manufacturing and development services to domestic and international partners.